A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

ישראלמגייס משתתפיםPHASE2

מצבים רפואיים

Solid Tumors Harboring MET Amplification

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Beverly Hills Cancer Center /ID# 275465, Beverly Hills, California, United States

  • City of Hope National Medical Center /ID# 275613, Duarte, California, United States

  • Valkyrie Clinical Trials /ID# 275547, Los Angeles, California, United States

  • Yale University School of Medicine /ID# 275978, New Haven, Connecticut, United States

  • Florida Cancer Specialists - North /ID# 277137, St. Petersburg, Florida, United States

  • Northwestern University Feinberg School of Medicine /ID# 276436, Chicago, Illinois, United States

  • University of Chicago Medical Center /ID# 275342, Chicago, Illinois, United States

  • START Midwest /ID# 276603, Grand Rapids, Michigan, United States

  • Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 275999, New York, New York, United States

  • Duke Cancer Institute /ID# 275604, Durham, North Carolina, United States

  • SCRI Oncology Partners /ID# 275686, Nashville, Tennessee, United States

  • UT Southwestern Medical Center /ID# 276053, Dallas, Texas, United States

  • The University of Texas MD Anderson Cancer Center /ID# 275663, Houston, Texas, United States

  • South Texas Accelerated Research Therapeutics (START) /ID# 276608, San Antonio, Texas, United States

  • Start Mountain Region /ID# 276607, West Valley City, Utah, United States

  • Virginia Cancer Specialists - Fairfax /ID# 276010, Fairfax, Virginia, United States

  • Rabin Medical Center. /ID# 274341, Petah Tikva, Central District, Israel

  • The Chaim Sheba Medical Center /ID# 274342, Ramat Gan, Tel Aviv, Israel

  • Tel Aviv Sourasky Medical Center /ID# 274344, Tel Aviv, Tel Aviv, Israel

  • Hadassah Medical Center-Hebrew University /ID# 274343, Jerusalem, Israel

  • Nagoya University Hospital /ID# 276336, Nagoya, Aichi-ken, Japan

  • National Cancer Center Hospital East /ID# 276298, Kashiwa-shi, Chiba, Japan

  • Kyushu University Hospital /ID# 276302, Fukuoka, Fukuoka, Japan

  • Hokkaido University Hospital /ID# 276333, Sapporo, Hokkaido, Japan

  • Kyoto University Hospital /ID# 276398, Kyoto, Kyoto, Japan

  • Tohoku University Hospital /ID# 276344, Sendai, Miyagi, Japan

  • Okayama University Hospital /ID# 276299, Okayama, Okayama-ken, Japan

  • National Cancer Center Hospital /ID# 276297, Chuo-Ku, Tokyo, Japan

  • Seoul National University Hospital /ID# 275703, Seoul, Seoul Teugbyeolsi, South Korea

  • Yonsei University Health System Severance Hospital /ID# 276184, Seoul, Seoul Teugbyeolsi, South Korea

  • Samsung Medical Center /ID# 275705, Seoul, Seoul Teugbyeolsi, South Korea

מובילי המחקר
  • ABBVIE INC.

    Study Director

    AbbVie